Abstract:There continues to be an ongoing need for fair and equitable organ allocation. The Model for End-Stage Liver Disease (MELD) score has evolved as a calculated framework to evaluate and allocate patients for liver transplantation objectively. The original MELD score has undergone multiple modifications as it is continuously scrutinized for its accuracy in objectively representing the clinical context of patients with liver disease. Several refinements and iterations of the score have been developed, including the widely accepted MELD-Na score. In addition, the most recent updated iteration, MELD 3.0, has been created. The MELD 3.0 calculator incorporates new variables such as patient sex and serum albumin levels and assigns new weights for serum sodium, bilirubin, international normalized ratio, and creatinine levels. It is anticipated that the use of MELD 3.0 scores will reduce overall waitlist mortality and enhance access for female liver transplant candidates. However, despite the emergence of the MELD score as one of the most objective measures for fair organ allocation, various countries and healthcare systems employ alternative methods for stratification and organ allocation. This review article will highlight the origins of the MELD score, its iterations, the current MELD 3.0, and future directions for managing liver transplantation organ allocation. Lay Summary Organ donation is crucial for the management of patients unwell with liver disease, but organs must be allocated fairly and equitably. One method used for this is the Model for End-Stage Liver Disease (MELD) score, which helps objectively decide which patient is a candidate for liver transplant. Over time, the MELD score has been refined to better reflect patients' needs. For example, the latest version, MELD 3.0, now considers factors like nutrition and gender. This should ensure that more patients, especially females, are candidates and receive appropriate access to liver transplantation. However, not every country uses the MELD score. Some countries have created their own scoring systems based on local research. This review will explain where the MELD score came from, how it has changed, the current characteristics of the MELD 3.0 score, and what the future might hold for organ allocation in liver transplants. Authors confirm their contribution to the article as follows: D.H.: investigation, writing—original draft, writing—review and editing. G.M., A.R., T.A., F.J.V.C., I.H.D.d.L., M.R.R.: writing—original draft, writing—review and editing. L.A.D., M.Q.K.: writing—review, editing, and supervision. J.P.A.: conceptualization, writing—review, editing, and supervision. Accepted Manuscript online: 08 November 2024 Article published online: 11 December 2024 © 2024. Thieme. All rights reserved. Thieme Medical Publishers, Inc. 333 Seventh Avenue, 18th Floor, New York, NY 10001, USA

[Review of Risk Evaluation Scores for Benign End Stage Liver Diseases Recipients].

Prediction Value of Model for End-Stage Liver Disease Scoring System on Prognosis in the Acute on Chronic Liver Failure Patients with Plasma Exchange Treatment.

[Clinical Evaluation of Emergency Liver Transplantation for Patients with Benign End-Stage Liver Diseases].

Therapeutic Evaluation of the Patients with High MELD Scores Undergoing Liver Transplantation for Benign End-Stage Liver Disease

Comparison of Different Scoring Systems Based on Both Donor and Recipient Characteristics for Predicting Outcome after Living Donor Liver Transplantation

Value of Pretransplant Albumin-Bilirubin Score in Predicting Outcomes after Liver Transplantation

Predicting short-term survival after liver transplantation on eight score systems: a national report from China Liver Transplant Registry

Survival status and risk factors of post-transplantation patients with end-stage liver disease

Dynamic evaluation based on acute-on-chronic liver failure predicts survival of patients after liver transplantation: a cohort study

[Analysis of 565 Cases of Liver Transplantation at a Single Transplantation Center].

Assessment of liver transplant benefit and a novel strategy for liver donor allocation in acute-on-chronic liver failure

Development of a Novel Prognostic Nomogram for High Model for End-Stage Liver Disease Score Recipients Following Deceased Donor Liver Transplantation

Liver Transplantation in Acute-on-chronic Liver Failure Patients with High Model for End-Stage Liver Disease (MELD) Scores: a Single Center Experience of 100 Consecutive Cases.

Does Model for End-Stage Liver Disease Score Predict the Short-Term Outcome of Living Donor Liver Transplantation?

Model for end-stage liver disease versus the Child-Pugh score in predicting the post-transplant 3-month and 1-year mortality in a cohort of Chinese recipients

Advancements in MELD Score and Its Impact on Hepatology

Adult-to-adult Right-Lobe Living Donor Liver Transplantation in High Model for End-Stage Liver Disease Score Recipients with Hepatitis B Virus-Related Benign Liver Diseases

Stratified Analysis of Survival Benefit for ABO-incompatible Deceased-donor Liver Transplantation: Multicenter Propensity Score-matched Study

Study of the survival quality of liver transplant recipients and its influential factors

[A New Model for Survival Assessment Based on the Chinese Liver Transplantation Patients with Hepatocellular Carcinoma].

Changing landscape of liver transplant in the United States- time for a new innovative way to define and utilize the "non-standard liver allograft"-a proposal